We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.34%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$55.7B
AUM Growth
-$11.4B
Cap. Flow
-$9.72B
Cap. Flow %
-17.45%
Top 10 Hldgs %
9.49%
Holding
4,137
New
382
Increased
1,324
Reduced
1,495
Closed
773

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$397M
2
YHOO
Yahoo Inc
YHOO
+$342M
3
BAC icon
Bank of America
BAC
+$322M
4
C icon
Citigroup
C
+$260M
5
BKNG icon
Booking.com
BKNG
+$219M

Sector Composition

Rank Sector Weight
1 Healthcare 13.78%
2 Technology 11.11%
3 Financials 10%
4 Consumer Discretionary 8.83%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSU
2251
DELISTED
Nevsun Resources Ltd.
NSU
$1.13M ﹤0.01%
347,314
-43,554
-11% -$130K
SM icon
2252
CALL
SM Energy
SM
$8.49B
$1.12M ﹤0.01%
60,000
+40,000
+200% +$552K
HCKT icon
2253
Hackett Group
HCKT
$278M
$1.12M ﹤0.01%
74,266
-2,966
-4% -$42.4K
FPO
2254
DELISTED
First Potomac Realty Trust
FPO
$1.12M ﹤0.01%
+123,961
New +$1.14M
AMBA icon
2255
PUT
Ambarella
AMBA
$3.1B
$1.12M ﹤0.01%
25,100
-113,100
-82% -$4.68M
SRI icon
2256
Stoneridge
SRI
$205M
$1.12M ﹤0.01%
77,019
+17,598
+30% +$221K
ACAD icon
2257
CALL
Acadia Pharmaceuticals
ACAD
$5.27B
$1.12M ﹤0.01%
+40,000
New +$872K
AXLL
2258
DELISTED
AXIALL CORP COM STK (DE)
AXLL
$1.12M ﹤0.01%
51,160
-1,641,403
-97% -$28.9M
WUBA
2259
PUT
DELISTED
58.com Inc
WUBA
$1.11M ﹤0.01%
+20,000
New +$1.1M
AIT icon
2260
Applied Industrial Technologies
AIT
$12.3B
$1.11M ﹤0.01%
25,583
+6,036
+31% +$238K
IMKTA icon
2261
Ingles Markets
IMKTA
$1.61B
$1.11M ﹤0.01%
29,530
+8,867
+43% +$317K
I.PRA
2262
DELISTED
INTELSAT S A MANDATORY CONV JR NON VTG PFD SHS (LUX)
I.PRA
$1.11M ﹤0.01%
150,000
ENVA icon
2263
Enova International
ENVA
$6.06B
$1.1M ﹤0.01%
175,109
+73,408
+72% +$439K
BAX icon
2264
Baxter International
BAX
$13.6B
$1.1M ﹤0.01%
26,799
+14,345
+115% +$547K
BANR icon
2265
Banner Corp
BANR
$2.39B
$1.1M ﹤0.01%
26,166
-12,568
-32% -$515K
ROST icon
2266
CALL
Ross Stores
ROST
$77.4B
$1.1M ﹤0.01%
19,000
-89,800
-83% -$4.99M
EGN
2267
CALL
DELISTED
Energen
EGN
$1.1M ﹤0.01%
+30,000
New +$929K
KW
2268
PUT
DELISTED
Kennedy-Wilson Holdings
KW
$1.09M ﹤0.01%
+50,000
New +$990K
PKY
2269
DELISTED
Parkway, Inc.
PKY
$1.09M ﹤0.01%
69,618
+47,977
+222% +$666K
MTSN
2270
DELISTED
MATTSON TECHNOLOGY INC
MTSN
$1.09M ﹤0.01%
298,848
-38,146
-11% -$135K
WFT
2271
CALL
DELISTED
Weatherford International plc
WFT
$1.09M ﹤0.01%
+140,000
New +$945K
ATRC icon
2272
AtriCure
ATRC
$2.48B
$1.09M ﹤0.01%
64,661
+33,664
+109% +$592K
PDCE
2273
DELISTED
PDC Energy, Inc.
PDCE
$1.09M ﹤0.01%
18,270
-74,893
-80% -$3.91M
TRST
2274
Trustco Bank Corp NY
TRST
$969M
$1.08M ﹤0.01%
35,791
+15,279
+74% +$437K
AVX
2275
DELISTED
AVX Corporation
AVX
$1.08M ﹤0.01%
86,250
+34,569
+67% +$402K

Similar funds

David Shaw's Q1 2016 Portfolio in Review

As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.

  • David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
  • David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
  • David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
  • David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
  • David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
  • David Shaw opened 382 new positions and closed 773 in Q1 2016.
  • David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.